A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis

Arthritis and Rheumatism
L GuillevinM Longy-Boursier

Abstract

To investigate the effectiveness and side effects of oral versus pulse cyclophosphamide (CYC) in combination with corticosteroids (CS) in the treatment of systemic Wegener's granulomatosis (WG). Patients with newly diagnosed systemic WG were enrolled in a prospective, randomized trial. At the time of diagnosis, prior to randomization, every patient received a daily injection of methylprednisolone for 3 days, followed by daily oral prednisone (1 mg/kg/day) and a 0.7-gm/m2 pulse of CYC. Patients were then randomly assigned to receive either prednisone plus intravenous pulse CYC (group A) or prednisone plus oral CYC (group B) as first-line treatment. CYC was given for at least 1 year and was then progressively tapered and discontinued. Fifty patients were included in the study: 27 in group A and 23 in group B. At 6 months, 24 group A patients (88.9%) were in remission, versus 18 group B patients (78.3%). At the end of the trial, 18 group A patients (66.7%) and 13 group B patients (56.5%) were in remission. In group A, 66.7% of the patients experienced side effects, versus 69.6% in group B. Infectious side effects were significantly more frequent in group B (69.6%) than in group A (40.7%) (P < 0.05). The incidence of Pneumocystis c...Continue Reading

References

Aug 2, 1979·The New England Journal of Medicine·A S FauciS M Wolff
Sep 1, 1992·Journal of Internal Medicine·A A DrososH M Moutsopoulos
Nov 1, 1992·Arthritis and Rheumatism·G S HoffmanA S Fauci
Mar 15, 1992·Annals of Internal Medicine·G S HoffmanA S Fauci
Jan 1, 1991·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M HaubitzK M Koch
Jan 1, 1989·Arthritis and Rheumatism·J D BradleyB P Katz
Jan 1, 1994·Current Opinion in Rheumatology·W L Gross
Mar 1, 1996·Annals of Internal Medicine·C Talar-WilliamsM C Sneller

❮ Previous
Next ❯

Citations

Jun 22, 1999·Thorax·C A Langford, G S Hoffman
Mar 18, 2000·Thorax·J F Cordier
Jun 26, 2003·Arthritis Research & Therapy·Carol A Langford
Mar 19, 2005·Critical Care : the Official Journal of the Critical Care Forum·David SempleRichard Venn
Jul 31, 2008·Annals of the Rheumatic Diseases·P A MerkelUNKNOWN Vasculitis Clinical Research Consortium
Nov 6, 2009·Arthritis Research & Therapy·Frank MoosigWolfgang L Gross
Nov 11, 2010·Journal of Athletic Training·James E LeoneRobert M Colandreo
Jul 5, 2011·Arthritis Research & Therapy·Julia U HolleWolfgang L Gross
Aug 16, 2019·Expert Review of Clinical Immunology·Christian Pagnoux, Arielle Mendel
May 5, 2017·Annals of the Rheumatic Diseases·Ju Ann TanJ Antonio Avina-Zubieta
May 16, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·K AasarødS Jørstad
Jan 23, 1999·Current Opinion in Rheumatology·W L Gross
Jun 25, 2016·Annals of the Rheumatic Diseases·M YatesC Mukhtyar
Dec 21, 2000·Current Rheumatology Reports·D T BoumpasN G Daskalakis
Sep 27, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·K de GrootUNKNOWN EUVAS (European vasculitis study group)
Jan 5, 2002·Expert Opinion on Investigational Drugs·C Thomas-Golbanov, S Sridharan
Jun 24, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anthony D BoothDavid R Jayne
Apr 22, 2004·QJM : Monthly Journal of the Association of Physicians·M A LittleK Farrington
Nov 18, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Irmgard NeumannFranz Thomas Meisl
Jan 19, 2005·Retina·Douglas A Jabs, Esen Karamursel Akpek
Dec 14, 2005·Current Opinion in Rheumatology·Bernhard HellmichWolfgang L Gross
Nov 4, 2006·HNO·C WittekindtK-B Hüttenbrink
Nov 30, 2006·Nature Clinical Practice. Rheumatology·Anoop KuttikatKuntal Chakravarty
Dec 7, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Avi LevinArie Ben-Yehuda
Nov 7, 2008·Nephrology·Solomon MenahemUNKNOWN Caring for Australians with Renal Impairment (CARI)
Apr 23, 2009·Nature Reviews. Nephrology·Lalit PallanLorraine Harper
Jun 25, 2010·BMC Nephrology·Giles D WaltersJonathan C Craig
Nov 30, 2010·Rheumatology·Raashid LuqmaniNigel Arden
Feb 22, 2011·Arthritis and Rheumatism·Guillaume Le GuennoUNKNOWN French Vasculitis Study Group
Aug 17, 2012·Current Rheumatology Reports·Duvuru Geetha, Philip Seo
Aug 11, 2012·Therapeutic Advances in Respiratory Disease·Zulma X YuntKevin K Brown
Feb 22, 2013·Expert Opinion on Pharmacotherapy·Robert M BeardsleyPhoebe Lin
Mar 14, 2013·The Journal of Laryngology and Otology·A K Ebrahim, J W Loock
Oct 18, 2014·Seminars in Ophthalmology·Eduardo UchiyamaLucia Sobrin
Mar 26, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·JulieAnne G McGregorSusan L Hogan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.